Results 21 to 30 of about 48,901 (273)
Background: In patients with ST-segment-elevation myocardial infarction (STEMI), it is essential to determine the complexity of coronary lesions on presentation and predict the risk of no-reflow after primary percutaneous coronary intervention (pPCI ...
A. Rostami +9 more
semanticscholar +1 more source
Background Accurate management of non-ST elevation myocardial infarction (NSTEMI) patients can be achieved by stratifying risks as early as possible on hospital admission.
Dileep Kumar +9 more
semanticscholar +1 more source
Ecology and effects of metazoan parasites of fish in transitional waters
Given the abundance, heterogeneity and ubiquity of parasitic organisms, understanding how they influence biodiversity, evolution, health and ecosystem functionality is crucial, especially currently when anthropogenic pressures are altering host-parasite ...
Timi, Juan Tomas +5 more
core +1 more source
BACKGROUND Sodium-glucose co-transporter-2 (SGLT2) inhibitors have shown beneficial effects on renal outcomes mainly in patients with established atherosclerotic cardiovascular disease.
Ofri Mosenzon +20 more
semanticscholar +1 more source
The funnel plot of TIMI myocardial perfusion grade III.
The funnel plot of TIMI myocardial perfusion grade III.
Xiaohui Li (73588) +4 more
core +1 more source
Standardized turbo codes (TCs) use recursive systematic convolutional transducers of rate b/(b + d), having a single feedback polynomial (b+dRSCT). In this paper, we investigate the realizability of the b+dRSCT set through two single shift register ...
Horia Balta +2 more
doaj +1 more source
Dapagliflozin reduced the risk of the composite of cardiovascular (CV) death or hospitalization for heart failure (HHF) in patients with type 2 diabetes mellitus in DECLARE‐TIMI 58. We hypothesized that baseline N‐terminal pro B‐type natriuretic peptide (
Thomas A. Zelniker +17 more
semanticscholar +1 more source
Background Patients with stable atherothrombotic disease vary in their risk of developing heart failure (HF). Circulating cardiovascular biomarkers may improve HF risk assessment and identify patients who may benefit from emerging HF preventive therapies.
David D. Berg +7 more
doaj +1 more source
Dynamic TIMI Risk Score for STEMI [PDF]
Background Although there are multiple methods of risk stratification for ST ‐elevation myocardial infarction ( STEMI ), this study presents a prospectively validated method for reclassification of patients based on in‐hospital events.
Amin, Sameer T. +6 more
openaire +2 more sources
To assess the associations between baseline glucose‐lowering agents (GLAs) and cardiorenal outcomes with dapagliflozin versus placebo in the DECLARE‐TIMI 58 study.
A. Cahn +17 more
semanticscholar +1 more source

